Fundraising Fox

Proteon Therapeutics

Waltham, US · Delaware corporation

Biotech

Founders & leadership

FN
F. Nicholas FrananoFounder
TK
Tony KingsleyExecutive
SK
Steven K. Burke, M.D.Executive
TP
Timothy P. NoyesExecutive
GA
George A. EldridgeExecutive
DP
Dean ProfisExecutive
TN
Timothy NoyesExecutive
MP
Matthew P. KowalskyNamed on SEC filing
PJ
Paul J. HastingsNamed on SEC filing
ES
E. Scott TonerNamed on SEC filing
SA
Scott A. CanuteNamed on SEC filing

Board

JG
John G. Freund, M.D.Board director

Reported raises · per SEC filings

Form D private placements

$55.9M disclosed across 3 rounds · 2013–2017

▶$22MraisedAug 2017 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew P. KowalskyExecutive Officer
  • Tony KingsleyDirector
  • John G. Freund, M.D.Director
  • Steven K. Burke, M.D.Executive Officer
  • Hubert Birner, Ph. D.Director
  • Jonathan LeffDirector
  • Paul J. HastingsDirector
  • E. Scott TonerExecutive Officer
  • Tim HainesDirector
  • Timothy P. NoyesExecutive Officer, Director
  • Scott A. CanuteDirector
  • George A. EldridgeExecutive Officer
  • Garen BohlinDirector
  • Daniel P. GottliebExecutive Officer
Offering amount
$22M
Amount sold
$22M
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.6MraisedMay 2014 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel P. GottliebExecutive Officer
  • Timothy NoyesExecutive Officer, Director
  • Hubert BirnerDirector
  • George EldridgeExecutive Officer
  • John G. FreundDirector
  • Steven K. BurkeExecutive Officer
  • F. Nicholas FrananoDirector
  • Todd FoleyDirector
  • Tim HainesDirector
  • Dmitry KobyzevDirector
  • Gregory D. PhelpsDirector
  • Brendan O'LearyDirector
Offering amount
$29.6M
Amount sold
$29.6M
First sale
May 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedFeb 2014 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen HoffmanDirector
  • Gregory D. PhelpsDirector
  • Dean ProfisExecutive Officer
  • F. Nicholas FrananoDirector
  • Hubert BirnerDirector
  • Timothy NoyesExecutive Officer, Director
  • Todd FoleyDirector
  • Brendan O'LearyDirector
Offering amount
$4.3M
Amount sold
$4.3M
First sale
Sep 2013
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Proteon Therapeutics?
Proteon Therapeutics was founded by F. Nicholas Franano.
How much funding has Proteon Therapeutics raised?
Proteon Therapeutics has disclosed $55.9M raised across 3 rounds.
Where is Proteon Therapeutics headquartered?
Proteon Therapeutics is headquartered in Waltham, US.